Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.26
Delayed Data
As of May 01
 -0.08 / -3.42%
Today’s Change
1.00
Today|||52-Week Range
8.46
-11.37%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.34
Today’s open2.33
Day’s range2.23 - 2.37
Volume599,758
Average volume (3 months)1,010,900
Market cap$159.6M
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+20.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales26.71
Price/Book10.82

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...+0.18+2.35%
GLYCGlycoMimetics Inc+0.02+0.24%
CERUCerulean Pharma Inc+0.02+0.34%
ANTHAnthera Pharmaceutic...+0.26+6.06%
Data as of 4:00pm ET, 05/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers